Physician profile
John W Waggoner
NPI 1922053016
$10,940.18
in general payments reported to CMS, 2019-2025
17 companies · $7,157 in 2025
The $7,157 reported for 2025 was more than what 86% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $446 · 2020: $163 · 2021: $651 · 2022: $622 · 2023: $1,808 · 2024: $92.10 · 2025: $7,157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,804 · Food and Beverage: $1,253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,804.28 |
| Food and Beverage | $1,253.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,889.52 | 2021-2025 | Avalus, Onyx Frontier, Symplicity G3 |
| Boston Scientific Corporation | $1,726.55 | 2019-2023 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Abbott Laboratories | $382.28 | 2021-2025 | Mitraclip |
| Abiomed | $233.45 | 2019-2024 | Impella |
| Chiesi USA, INC. | $142.78 | 2019-2020 | |
| Amgen INC. | $111.39 | 2020-2023 | Repatha |
| Atricure, INC. | $82.45 | 2022 | |
| Janssen Pharmaceuticals, INC | $72.79 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $72.32 | 2019 | |
| Philips North America LLC | $58.84 | 2020-2025 | Event |
| Astrazeneca Pharmaceuticals LP | $41.84 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $40.89 | 2019-2020 | |
| Medtronic Vascular, INC. | $19.81 | 2020 | |
| Biotronik INC. | $17.86 | 2021 | |
| Teleflex LLC | $17.76 | 2025 | Guideliner |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $15.56 | 2019 | |
| Getinge USA Sales, LLC | $14.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Waggoner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.